MediciGlobal (Philadelphia and London) has released a new version of ADapt, its Web-based system that customizes patient recruitment materials based on a study's geography. Since being introduced in early 2008, over 235 users have employed the system to translate patient materials, linguistically adapt them, and initiate the IRB submissions process.
"The power of this system is that we're pushing patient recruitment down to the local level and achieving this faster than conventional methods," says Liz Moench, MediciGlobal's President and Chief Executive Officer.
"ADapt brings speed, quality, localization, and local team buy-in, and all this is achieved more cost effectively."
What users can expect from the latest version of ADapt are faster operating times and paperless Ethics/IRB submission and approval tracking. Other enhancements include:
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.